6 not yet recruiting, 4 completed, 3 active not recruiting, 1 recruiting. 8 Not applicable, 3 Phase 3, 3 Phase 4, 2 Phase 2.
Follow Acute Decompensated Heart Failure (ADHF): new trials by email Literature Review of Acute Decompensated Heart Failure (ADHF) trials Research Report on Acute Decompensated Heart Failure (ADHF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of FlowMod System While Intermittently Partially Occluding Vena Cava Blood Flow in Subjects With ADHF FlowMod System in subjects with acute decompensated heart failure (ADHF) - Acute Decompensated Heart Failure (ADHF) | Not applicable | Not yet recruiting | FlowMod, Inc. | 30 | 2026-09-05 | 2026-09-09 |
| Bedside NT-proBNP Monitoring in Acute Heart Failure Serial NT-proBNP Measurement - Acute Decompensated Heart Failure (ADHF) | Not yet recruiting | Mao Chen | 50 | 2026-08-15 | 2026-08-13 | |
| Efficacy and Safety of Compression Boots in Patients With Acute Decompensated Heart Failure. Pulsatile Compression Boots (PCB) - Acute Decompensated Heart Failure (ADHF) | Not applicable | Not yet recruiting | Odense University Hospital | 100 | 2026-01-01 | 2026-01-29 |
| Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure Empagliflozin 10 MG Oral Tablet [Jardiance], Placebo - Acute Decompensated Heart Failure (ADHF) | Phase 3 | Recruiting | Christian Schulze | 536 | 2025-12-08 | 2026-11-04 |
| Levosimendan in Acute Decompensated Heart Failure Levosimendan, Standard care - Acute Decompensated Heart Failure (ADHF) | Phase 2 / Phase 3 | Not yet recruiting | Chittagong Medical College | 332 | 2025-12-01 | 2025-12-04 |
| The Effect of Dapagliflozin on Patients With Cardiomyopathy Dapagliflozin (DAPA), Diuretic - Acute Decompensated Heart Failure (ADHF) | Phase 4 | Completed | May Mohamed Abdalla | 100 | 2025-08-01 | 2026-09-15 |
| ExCR's Effects and Safety in Vulnerable ADHF Patients Exercise rehabilitation, Conventional rehabilitation - Acute Decompensated Heart Failure (ADHF) | Not applicable | Not yet recruiting | YE Jing | 88 | 2025-02-17 | 2025-01-28 |
| Bedside Ultrasound-guided Volume Management and Discharge Timing for Patients With Heart Failure During Hospitalization: A Randomized Controlled Trial Ultrasound-Guided Volume Assessment and Decongestion Strategy (UVADS), clinical assessment - Acute Decompensated Heart Failure (ADHF) | Not applicable | Active not recruiting | Pan He | 150 | 2025-02-01 | 2025-07-01 |
| Left Ventricular Impella Device Real-World Evaluation in Pediatric Patients Impella CP with SmartAssist, Impella 5.5 with SmartAssist - Cardiogenic Shock, Heart Failure | Active not recruiting | Abiomed Inc. | 60 | 2024-12-03 | 2026-11-17 | |
| Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction Remote dielectric sensing system - Acute Myocardial Infarction, Acute Decompensated Heart Failure (ADHF) | Not applicable | Not yet recruiting | Shanghai 10th People's Hospital | 2000 | 2024-11-01 | 2024-11-04 |
| Comparison of the Effectiveness of Different Diuretic Therapies in the Management of Acute Heart Failure Furosemide Bolus, Furosemide Continuous İnfusion - Acute Decompensated Heart Failure (ADHF) | Not applicable | Completed | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 50 | 2024-04-03 | 2026-03-11 |
| Natriuresis With Acetazolamide or SGLT2 Inhibitors Added to Intravenous Loop Diuretics in Decompensated Heart Failure Furosemide, Acetazolamide, Dapagliflozin - Heart Failure, Acute Decompensated Heart Failure (ADHF) | Phase 4 | Active not recruiting | Universidade do Porto | 68 | 2024-03-11 | 2026-11-09 |
| Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure Sacubitril / Valsartan, Ramipril (ACE-inhibitor) - Acute Decompensated Heart Failure (ADHF), Chronic Kidney Disease (CKD) | Phase 2 / Phase 3 | Completed | National Heart Institute, Egypt | 515 | 2023-11-01 | 2026-08-13 |
| Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function Levosimendan, Dobutamine, Milrinone - Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome (CRS) | Phase 4 | Completed | Ain Shams University | 60 | 2022-06-01 | 2026-09-21 |
| Acute Congestive Heart Failure non-invasive respiratory parameter measurements - Acute Decompensated Heart Failure (ADHF), Acute Cardiogenic Pulmonary Edema (ACPE) | Not applicable | Unknown | RWTH Aachen University | 50 | 2013-06-01 | 2015-09-23 |
| Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment Isolated veno-venous ultrafiltration (AQ), IV Loop Diuretics (LD) - Heart Failure, Cardiac Failure | Not applicable | Terminated | Nuwellis, Inc. | 224 | 2012-01-01 | 2023-08-29 |
Heart Failure (5) · Cardio-Renal Syndrome (2) · Cardiomyopathies (1) · Myocarditis (1) · Renal Insufficiency, Chronic (1) · Shock, Cardiogenic (1)
Cardiovascular Diseases (6) · Heart Diseases (6) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Renal Insufficiency (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chronic Disease (1) · Disease Attributes (1) · Heart Failure (1) · Infarction (1)
Furosemide (2) · Simendan (2) · dapagliflozin (2) · empagliflozin (2) · Acetazolamide (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Diuretics (1) · Dobutamine (1) · Exercise Therapy (1) · Intermittent Pneumatic Compression Devices (1) · Milrinone (1) · Ramipril (1) · Sodium Potassium Chloride Symporter Inhibitors (1) · Standard of Care (1) · Tablets (1)
Abiomed Inc. (1) · Ain Shams University (1) · Chittagong Medical College (1) · Christian Schulze (1) · FlowMod, Inc. (1) · Mao Chen (1) · May Mohamed Abdalla (1) · National Heart Institute, Egypt (1) · Nuwellis, Inc. (1) · Odense University Hospital (1) · Pan He (1) · RWTH Aachen University (1) · Shanghai 10th People's Hospital (1) · Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey (1) · Universidade do Porto (1)
China (3) · Egypt (3) · Germany (2) · United States (2) · Bangladesh (1) · Denmark (1) · Georgia (1) · Portugal (1) · Turkey (Türkiye) (1) · Uzbekistan (1)
Baiyu Zhang (1) · Freja S. Madsen, M.D., Ph.D student (1) · Hesham Salah Eldin Taha, MD (1) · Jing Ye, MSN. (1) · Lei Yang (1) · Lihua Zhao, MSN. (1) · Maria Rosa Costanzo, MD (1) · Omar Younis, Msc (1) · Pedro M. Marques, MD (1) · Wenhui Ding, Prof. (1) · Xiaoning Han, Ph.D. (1) · Yidong Wei, M.D., Ph.D. (1) · Yimeng Jiang, Ph.D. (1) · Yuling Wang (1)